5% of good news is still good news (just less)

[biopearl123]

LCTX, which as old timers recall was spun off when Dr. Scarlett assumed the reins (or perhaps reign would also apply), has inked a deal with Genentech for development of its optical cell therapy for dry AMD. Genentech pays an upfront 50 M and assumes development responsibilities. It’s nice to see cell based therapies advance. Geron gets a 5% royalty on LCTX sales if I remember correctly. I expect that since this is such pioneering therapy that the FDA approval slow boat we have come to know will require large studies and that 5% may be a while in coming to fruition. Still, its good news.